Harold Stites, MD
Clinical Cardiac Electrophysiology · Cape Girardeau, MONPI 1679530463
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.8% of the total across 379 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Abbott at 30.6% of the total. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in MO, where the typical reported total is $14,594.
Across 379 payments — averaging $15.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Medtronic$2K
- Boston Scientific$1K
- Cvrx, Inc.$399
- Biosense Webster, Inc.$290
- Novartis$165
- plus $639 from 13 others
What the payments were for
- Travel & lodging$2354%
- Food & beverage$5,37892%
- Education$2484%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 76 | $1,794 |
| Medtronic(2 entities) | 185 | $1,509 |
| Boston Scientific | 76 | $1,065 |
| Cvrx, Inc. | 3 | $399 |
| Biosense Webster, Inc. | 2 | $290 |
| Novartis | 9 | $165 |
| Amgen | 10 | $165 |
| Biotronik Inc. | 2 | $129 |
| Abiomed | 1 | $110 |
| Johnson & Johnson | 6 | $86 |
| AstraZeneca | 1 | $23 |
| Lantheus Medical Imaging, Inc. | 1 | $22 |
| Irhythm Technologies, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Edwards Lifesciences | 1 | $17 |
| Boehringer Ingelheim | 1 | $15 |
| Regeneron Healthcare Solutions, Inc. | 1 | $13 |
| Pfizer | 1 | $12 |
| E.r. Squibb & Sons, L.L.C. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENSITE$427
- Barostim Neo System$399
- WATCHMAN Access System$269
- AVEIR$226
- QUADRA ASSURA$180
- Carto 3$149
- QDOT MICRO Catheter$141
- Farapulse$132
- Impella$110
- ENSITE PRECISION$108
- ENTRESTO$101
How this compares
$5,862 in reported general payments places this provider in the 30th percentile of 74 clinical cardiac electrophysiology providers in Missouri.
See all clinical cardiac electrophysiology providers in Missouri →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 400 | $290,908 |
| XareltoRivaroxaban | 60 | $54,316 |
| Dofetilide | 116 | $19,436 |
| JardianceEmpagliflozin | 18 | $17,386 |
| EntrestoSacubitril/Valsartan | 25 | $17,158 |
| CorlanorIvabradine Hcl | 14 | $9,113 |
| Amiodarone Hcl | 302 | $5,357 |
| Nadolol | 53 | $2,757 |
| Flecainide Acetate | 127 | $2,302 |
| Metoprolol Succinate | 220 | $2,049 |
| Mexiletine Hcl | 18 | $1,526 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 76 | $1,018 |
| Carvedilol | 212 | $849 |
| Potassium Chloride | 72 | $694 |
| Furosemide | 148 | $581 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $12 | $290,908400 claims |
| Johnson & JohnsonXarelto | $86 | $54,31660 claims |
| Boehringer IngelheimJardiance | $15 | $17,38618 claims |
| NovartisEntresto | $165 | $17,15825 claims |
| AmgenCorlanor | $165 | $9,11314 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 74 clinical cardiac electrophysiology providers in Missouri.
Other clinical cardiac electrophysiology in Cape Girardeau
- Dennis GlascockCape Girardeau$39K
- Phillip CuculichSaint Louis$473K
- Sanjaya GuptaKansas City$316K
- Daniel CooperSaint Louis$168K
- Jessica KlineKansas City$75K
- Mahmoud ElsayedNorth Kansas City$67K
- Scott KoerberIndependence$58K
- Krasimira MikhovaSaint Louis$52K
- Gregory BotteronSaint Louis$52K
- Shang-Chiun LeeSpringfield$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.